These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 27238066)

  • 21. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance abuse in patients with attention-deficit/hyperactivity disorder.
    Bukstein O
    Medscape J Med; 2008 Jan; 10(1):24. PubMed ID: 18324334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion.
    Faraone SV; Upadhyaya HP
    J Clin Psychiatry; 2007 Nov; 68(11):e28. PubMed ID: 18052554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.
    Chang Z; Quinn PD; O'Reilly L; Sjölander A; Hur K; Gibbons R; Larsson H; D'Onofrio BM
    Biol Psychiatry; 2020 Sep; 88(6):452-458. PubMed ID: 31987492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulant ADHD medication and risk for substance abuse.
    Chang Z; Lichtenstein P; Halldner L; D'Onofrio B; Serlachius E; Fazel S; Långström N; Larsson H
    J Child Psychol Psychiatry; 2014 Aug; 55(8):878-85. PubMed ID: 25158998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
    Mannuzza S; Klein RG; Truong NL; Moulton JL; Roizen ER; Howell KH; Castellanos FX
    Am J Psychiatry; 2008 May; 165(5):604-9. PubMed ID: 18381904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; Werner KS; McCabe VV; Veliz PT
    Psychiatr Serv; 2024 Jul; 75(7):622-629. PubMed ID: 38321920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing attention-deficit/hyperactivity disorder in children and adolescents.
    McClain EK; Burks EJ
    Prim Care; 2015 Mar; 42(1):99-112. PubMed ID: 25634708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
    Molina BSG; Kennedy TM; Howard AL; Swanson JM; Arnold LE; Mitchell JT; Stehli A; Kennedy EH; Epstein JN; Hechtman LT; Hinshaw SP; Vitiello B
    JAMA Psychiatry; 2023 Sep; 80(9):933-941. PubMed ID: 37405756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptoms of Depression and ADHD in Relation to Stimulant Medication Misuse Among College Students.
    Benson K; Flory K
    Subst Use Misuse; 2017 Dec; 52(14):1937-1945. PubMed ID: 28753050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of medication by young people with attention-deficit/hyperactivity disorder.
    Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
    Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.